IT8067302A0 - Agente antitumorale - Google Patents

Agente antitumorale

Info

Publication number
IT8067302A0
IT8067302A0 IT8067302A IT6730280A IT8067302A0 IT 8067302 A0 IT8067302 A0 IT 8067302A0 IT 8067302 A IT8067302 A IT 8067302A IT 6730280 A IT6730280 A IT 6730280A IT 8067302 A0 IT8067302 A0 IT 8067302A0
Authority
IT
Italy
Prior art keywords
anticancer agent
anticancer
agent
Prior art date
Application number
IT8067302A
Other languages
English (en)
Other versions
IT1129802B (it
Inventor
Masahiko Mutai Teruo Yokokura
Seizaburo Kobayashi
Ikuo Kato
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Publication of IT8067302A0 publication Critical patent/IT8067302A0/it
Application granted granted Critical
Publication of IT1129802B publication Critical patent/IT1129802B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IT67302/80A 1979-02-27 1980-02-27 Agente antitumorale IT1129802B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2133979A JPS55113718A (en) 1979-02-27 1979-02-27 Antitumor agent

Publications (2)

Publication Number Publication Date
IT8067302A0 true IT8067302A0 (it) 1980-02-27
IT1129802B IT1129802B (it) 1986-06-11

Family

ID=12052351

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67302/80A IT1129802B (it) 1979-02-27 1980-02-27 Agente antitumorale

Country Status (12)

Country Link
US (1) US4347240A (it)
JP (1) JPS55113718A (it)
BR (1) BR8001129A (it)
CA (1) CA1124176A (it)
CH (1) CH653556A5 (it)
DE (1) DE3007412A1 (it)
FR (1) FR2450108B1 (it)
HK (1) HK23784A (it)
IT (1) IT1129802B (it)
MY (1) MY8500010A (it)
NL (1) NL189999C (it)
SG (1) SG38183G (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3125797A1 (de) * 1981-06-30 1983-01-13 Rudolf Dr. Schuler Diaetetisches mittel
US5965414A (en) * 1985-11-04 1999-10-12 Microlife Technics, Inc. Process for producing yeast and mold inhibiting products with lactobacillus
JPH0696538B2 (ja) * 1985-12-19 1994-11-30 株式会社アドバンス 抗発癌剤
WO1991005851A1 (en) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Bacterium strain lactobacillus casei subsp. casei 37 for production of a bacterial biological preparation
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
WO1994026114A1 (en) * 1993-05-11 1994-11-24 Immunom Technologies, Inc. Method of stimulating and modulating the immune system of animals with microbial compositions
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
EP0974666A4 (en) 1996-06-26 2004-12-15 Yakult Honsha Kk METHODS FOR TRANSFERRING GENES INTO A CHROMOSOME
WO1998035014A2 (en) * 1997-02-11 1998-08-13 Enterprise Ireland Trading As Bioresearch Ireland Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
ATE493139T1 (de) * 1997-04-18 2011-01-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
WO2005000222A2 (en) * 2003-05-30 2005-01-06 Amylin Pharmaceuticals, Inc. Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
US20050112097A1 (en) * 2003-11-26 2005-05-26 Hinton Golden S. Method for the treatment of cancer
DK1853284T3 (da) * 2005-02-11 2014-07-14 Biolactis Inc Anvendelse af Lactobacillus kefiranofaciens som probiotikum og synbiotikum
US8404823B2 (en) * 2006-10-27 2013-03-26 Kabushiki Kaisha Yakult Honsha Cytokine production regulator gene and use thereof
EP2630961B1 (en) * 2006-11-02 2014-11-26 Aureo Co., Ltd. Agent for promoting healing of a wound of a living body
KR20100008831A (ko) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물
CA2779418C (en) 2009-11-11 2018-03-20 Alimentary Health Limited Probiotic bifidobacterium strain
AU2010317423C1 (en) 2009-11-11 2015-01-22 Alimentary Health Limited A bifidobacterium strain
US11590179B2 (en) 2017-02-28 2023-02-28 Precisionbiotics Group Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
CA3092728A1 (en) 2017-03-23 2018-09-27 Universiteit Antwerpen A novel probiotic lactobacillus casei strain and its uses
WO2021180973A1 (en) 2020-03-13 2021-09-16 Precisionbiotics Group Limited Bifidobacterium longum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1514949A (fr) * 1965-06-01 1968-03-01 Texim Entpr Economique D Etat Procédé de fabrication d'une nouvelle substance à partir de culture de microorganisme du genre lactobacillus
US3632746A (en) * 1967-08-30 1972-01-04 Chugai Pharmaceutical Co Ltd Dried stable anti-tumor preparations and process for preparing the same
FR2244464A1 (en) * 1973-06-26 1975-04-18 Serozym Laboratoires Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.

Also Published As

Publication number Publication date
HK23784A (en) 1984-03-23
US4347240A (en) 1982-08-31
FR2450108B1 (fr) 1988-10-28
CA1124176A (en) 1982-05-25
SG38183G (en) 1984-07-20
NL189999B (nl) 1993-05-03
JPS55113718A (en) 1980-09-02
DE3007412A1 (de) 1980-11-06
IT1129802B (it) 1986-06-11
CH653556A5 (de) 1986-01-15
NL189999C (nl) 1993-10-01
BR8001129A (pt) 1980-11-04
NL8001045A (nl) 1980-08-29
MY8500010A (en) 1985-12-31
FR2450108A1 (fr) 1980-09-26
JPS6234727B2 (it) 1987-07-28

Similar Documents

Publication Publication Date Title
IT8067302A0 (it) Agente antitumorale
IT8148302A0 (it) Agente antiallergico
FI65323B (fi) Foerfarande foer minskning av nox-straolning
FI64188B (fi) Foerfarande foer selektiv lakning av nickel-kopparskaersten
NO800164L (no) Roentgen-kontrastmiddel.
FI791512A (fi) Foerfarande foer foam-skin isolering av telefontraodar
IT1167986B (it) Agente analgesico
IT7850273A0 (it) Agente antitumorale
FI791513A (fi) Foerfarande foer snabb reglering av telefontraodars skumplastisoleringsprocess
IT1064474B (it) Agente deodorante
FI791059A (fi) Foerfarande foer framstaellning av en haeftplastprodukt
FI801023A (fi) Foerfarande foer framstaellning av benzotiazolderivat
FI790162A (fi) Jordbearbetningsanordning foer bearbetning av skogsmark
AT368889B (de) Radiodiagnostikum
AT355693B (de) Wasserverduennbares waermehaertendes ueberzugs- mittel
IT1128169B (it) Agente antivirale cpmprendente 1-b-d-arabinofuranosil-timina
ATA498179A (de) Katheter
IT7922026A0 (it) Agente ipolipideamico.
BR7802126A (pt) Agente explosivo fluivel
BE874278A (fr) Coffre-fort
IT1094895B (it) Agente antivirale
FI791627A (fi) Laosnings- och avfyrningsanordning av bogserkrok
IT7868367A0 (it) Agente anticancro
IT1080081B (it) Agente fungicida
ATA133684A (de) Fungizide mittel

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970228